<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: atrophy</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Study: Alzheimer's disease symptoms more subtle in people over 80</title>
   	 <description>A new study suggests that the relationship between brain shrinkage and memory loss in Alzheimer's disease changes across the age spectrum. The research is published in the August 10, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.</description>
     <link>http://medicalxpress.com/news/2011-08-alzheimer-disease-symptoms-subtle-people.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 10 Aug 2011 17:08:07 EST</pubDate>
	 <guid isPermaLink="false">news232214857</guid>
	 
</item>
<item>
     <title>Mice point to a therapy for Charcot-Marie-Tooth disease</title>
   	 <description>VIB researchers have developed a mouse model for Charcot-Marie-Tooth (CMT) neuropathy, a hereditary disease of the peripheral nervous system. They also found a potential therapy for this incurable disease.  The treatment not only halted the damage to the nerves and the atrophy of the muscles, it even succeeded in reversing the symptoms. </description>
     <link>http://medicalxpress.com/news/2011-08-mice-therapy-charcot-marie-tooth-disease.html</link>
	 <category>Dentistry</category>
	 <pubDate>Tue, 02 Aug 2011 13:10:07 EST</pubDate>
	 <guid isPermaLink="false">news231505760</guid>
	 
</item>
<item>
     <title>Pregnancy hormone has unprecedented, powerful effect on spinal muscular atrophy</title>
   	 <description>Researchers in Ottawa report new hope for the treatment of infants born with serious genetic disorder.</description>
     <link>http://medicalxpress.com/news/2011-07-insight-therapeutic-approach-spinal-muscular.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 25 Jul 2011 13:20:53 EST</pubDate>
	 <guid isPermaLink="false">news230818844</guid>
	 
</item>
<item>
     <title>'Westie' dogs research may hold answers to similar human diseases</title>
   	 <description>The Westie Foundation of America (WFA) announced today preliminary findings in two major studies involving the health of West Highland White Terriers also known as Westies. Findings in these and other studies of Westies and other dogs may hold answers for similar human conditions like Inflammatory Bowel Disease (IBD). The studies are jointly funded by the WFA and the AKC Canine Health Foundation (CHF).</description>
     <link>http://medicalxpress.com/news/2011-07-westie-dogs-similar-human-diseases.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 18 Jul 2011 16:44:39 EST</pubDate>
	 <guid isPermaLink="false">news230226262</guid>
	 
</item>
<item>
     <title>Failure in nerve-fiber navigation corrected in zebrafish model, suggests possibility of drug treatment</title>
   	 <description>Spinal muscular atrophy (SMA) is the leading genetic cause of death in children under 2, with no treatment other than supportive care. In the Proceedings of the National Academy of Sciences, researchers at Children's Hospital Boston show how loss or mutation of the SMA gene causes progressive muscle degeneration and weakness, and suggest a promising approach to treating the condition, sometimes referred to as a &quot;Lou Gehrig's disease of babies.&quot;</description>
     <link>http://medicalxpress.com/news/2011-06-failure-nerve-fiber-zebrafish-possibility-drug.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 06 Jun 2011 15:00:09 EST</pubDate>
	 <guid isPermaLink="false">news226576963</guid>
	 
</item>
<item>
     <title>Losartan protects against loss of old or damaged muscle: study</title>
   	 <description>Using geriatric mice, a Johns Hopkins research team has shown that losartan, a commonly used blood pressure drug,  not only improves regeneration of injured muscle but also protects against its wasting away from inactivity.</description>
     <link>http://medicalxpress.com/news/2011-05-losartan-loss-muscle.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 11 May 2011 14:00:16 EST</pubDate>
	 <guid isPermaLink="false">news224338835</guid>
	 
</item>
<item>
     <title>Research identifies risk factors associated with progression of glaucoma</title>
   	 <description>Elevated pressure inside the eye, cornea thinning, and visual field loss are all markers that glaucoma may progress, according to a report in the May issue of Archives of Ophthalmology.</description>
     <link>http://medicalxpress.com/news/2011-05-factors-glaucoma.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 09 May 2011 17:06:59 EST</pubDate>
	 <guid isPermaLink="false">news224179593</guid>
	 
</item>
<item>
     <title>Oral drug for MS significantly reduces disease activity and slows disability</title>
   	 <description>The drug laquinimod reduced the number of relapses for people with multiple sclerosis (MS), in a large, long-term Phase III clinical study that will be presented as late-breaking research at the 63rd Annual Meeting of the American Academy of Neurology, April 9-16, 2011, in Honolulu.</description>
     <link>http://medicalxpress.com/news/2011-04-oral-drug-ms-significantly-disease.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 11 Apr 2011 17:00:02 EST</pubDate>
	 <guid isPermaLink="false">news221758418</guid>
	 
</item>
<item>
     <title>Vision loss slowed by encapsulated cell therapy</title>
   	 <description>(PhysOrg.com) -- A phase 2 clinical trial for the treatment of a severe form of age-related macular degeneration called geographic atrophy (GA) has become the first study to show the benefit of a therapy to slow the progression of vision loss for this disease. The results highlight the benefit of the use of a neurotrophic factor to treat GA and provide hope to nearly one million Americans suffering from GA.</description>
     <link>http://medicalxpress.com/news/2011-04-vision-loss-encapsulated-cell-therapy.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 07 Apr 2011 07:51:13 EST</pubDate>
	 <guid isPermaLink="false">news221381418</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/visionlossin.jpg" width="90" height="90" />
</item>


</channel>
</rss>
